Terms: = Colorectal cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Prognosis
500 results:
1. Identification of extracellular matrix-related biomarkers in colon adenocarcinoma by bioinformatics and experimental validation.
Yin Y; Yang X; Cheng Z; Wang H; Lei J; Wang D; Wang P; Li B; Mi J; Yuan Q
Front Immunol; 2024; 15():1371584. PubMed ID: 38694509
[TBL] [Abstract] [Full Text] [Related]
2. PTPLAD1 Regulates PHB-Raf Interaction to Orchestrate Epithelial-Mesenchymal and Mitofusion-Fission Transitions in colorectal cancer.
Huang ZJ; Li YJ; Yang J; Huang L; Zhao Q; Lu YF; Hu Y; Zhang WX; Liang JZ; Pan J; Pan YL; He QY; Wang Y
Int J Biol Sci; 2024; 20(6):2202-2218. PubMed ID: 38617530
[TBL] [Abstract] [Full Text] [Related]
3. Multi-omics cluster defines the subtypes of CRC with distinct prognosis and tumor microenvironment.
Ma Y; Li J; Zhao X; Ji C; Hu W; Ma Y; Qu F; Sun Y; Zhang X
Eur J Med Res; 2024 Mar; 29(1):207. PubMed ID: 38549156
[TBL] [Abstract] [Full Text] [Related]
4. S100A6 mediated epithelial-mesenchymal transition affects chemosensitivity of colorectal cancer to oxaliplatin.
Zhang C; Zeng M; Xu Y; Huang B; Shi P; Zhu X; Cao Y
Gene; 2024 Jul; 914():148406. PubMed ID: 38521111
[TBL] [Abstract] [Full Text] [Related]
5. microRNA-15a-5p suppresses hypoxia-induced tumor growth and chemoresistance in bladder cancer by binding to eIF5A2.
Yang J; Xiang H; Cheng M; Jiang X; Chen Y; Zheng L; Yan S; Zhang S; Zhang C; Chen W; Chen D
Neoplasma; 2024 Feb; 71(1):60-69. PubMed ID: 38506035
[TBL] [Abstract] [Full Text] [Related]
6. Decreased interleukin-17RA expression is associated with good prognosis in patients with colorectal cancer and inhibits tumor growth and vascularity in mice.
Jiang JK; Lin CH; Chang TA; Lo LC; Lin CP; Lu RH; Yang CY
Cancer Med; 2024 Mar; 13(5):e7059. PubMed ID: 38491831
[TBL] [Abstract] [Full Text] [Related]
7. Canonical DDR activation by emt inducing agent 5-Fluorouracil is modulated by a cannabinoid based combinatorial approach via inducing autophagy and suppression of vimentin expression.
Mir KB; Chakraborty S; Amin T; Kumar A; Rouf War A; Nalli Y; Kumar R; Dinesh Kumar L; Ali A; Goswami A
Biochem Pharmacol; 2024 May; 223():116126. PubMed ID: 38490521
[TBL] [Abstract] [Full Text] [Related]
8. A comprehensive multi-omics analysis identifies a robust scoring system for cancer-associated fibroblasts and intervention targets in colorectal cancer.
Wang F; Li Z; Xu T; Zhang Q; Ma T; Li S; Wang X
J Cancer Res Clin Oncol; 2024 Mar; 150(3):124. PubMed ID: 38478111
[TBL] [Abstract] [Full Text] [Related]
9. Cellular senescence is associated with the spatial evolution toward a higher metastatic phenotype in colorectal cancer.
Park SS; Lee YK; Choi YW; Lim SB; Park SH; Kim HK; Shin JS; Kim YH; Lee DH; Kim JH; Park TJ
Cell Rep; 2024 Mar; 43(3):113912. PubMed ID: 38446659
[TBL] [Abstract] [Full Text] [Related]
10. A prognostic marker LTBP1 is associated with epithelial mesenchymal transition and can promote the progression of gastric cancer.
Jiang X; Yin S; Yin X; Wang Y; Fang T; Yang S; Bian X; Li G; Xue Y; Zhang L
Funct Integr Genomics; 2024 Feb; 24(1):30. PubMed ID: 38358412
[TBL] [Abstract] [Full Text] [Related]
11. Small extracellular vesicles promote the formation of the pre-metastatic niche through multiple mechanisms in colorectal cancer.
Wu J; Wang X; Li Z; Yi X; Hu D; Wang Q; Zhong T
Cell Cycle; 2024 Jan; 23(2):131-149. PubMed ID: 38341861
[TBL] [Abstract] [Full Text] [Related]
12. Th17 Cells Secrete TWEAK to Trigger Epithelial-Mesenchymal Transition and Promote colorectal cancer Liver Metastasis.
Liu X; Wang X; Yang Q; Luo L; Liu Z; Ren X; Lei K; Li S; Xie Z; Zheng G; Zhang Y; Hao Y; Zhou Q; Hou Y; Fang F; Song W; Cui J; Ma J; Xie W; Shen S; Tang C; Peng S; Yu J; Kuang M; Song X; Wang F; Xu L
Cancer Res; 2024 Apr; 84(8):1352-1371. PubMed ID: 38335276
[TBL] [Abstract] [Full Text] [Related]
13. Effect of Cichoric Acid on colorectal cancer: Impact on Migration, Epithelial-Mesenchymal Transition, and Proliferation
Ma S; Huang Z; Chen Q; Yin X
Discov Med; 2024 Jan; 36(180):190-198. PubMed ID: 38273759
[TBL] [Abstract] [Full Text] [Related]
14. LOXL1 promotes tumor cell malignancy and restricts CD8 + T cell infiltration in colorectal cancer.
Li C; Chen S; Fang X; Du Y; Guan XY; Lin R; Xu L; Lan P; Yan Q
Cell Biol Toxicol; 2024 Jan; 40(1):6. PubMed ID: 38267662
[TBL] [Abstract] [Full Text] [Related]
15. A partial epithelial-mesenchymal transition signature for highly aggressive colorectal cancer cells that survive under nutrient restriction.
Pastorino GA; Sheraj I; Huebner K; Ferrero G; Kunze P; Hartmann A; Hampel C; Husnugil HH; Maiuthed A; Gebhart F; Schlattmann F; Gulec Taskiran AE; Oral G; Palmisano R; Pardini B; Naccarati A; Erlenbach-Wuensch K; Banerjee S; Schneider-Stock R
J Pathol; 2024 Mar; 262(3):347-361. PubMed ID: 38235615
[TBL] [Abstract] [Full Text] [Related]
16. High MEIS3 Expression Indicates a Poor prognosis for Patients with Stage II/III colorectal cancer.
Ma J; Li H; Gao Q; Zhang W; Zhu C; Chen J; Ling Y; Shao X; Li Z
Front Biosci (Landmark Ed); 2023 Dec; 28(12):338. PubMed ID: 38179750
[TBL] [Abstract] [Full Text] [Related]
17. H19: An Oncogenic Long Non-coding RNA in colorectal cancer.
Chowdhury PR; Salvamani S; Gunasekaran B; Peng HB; Ulaganathan V
Yale J Biol Med; 2023 Dec; 96(4):495-509. PubMed ID: 38161577
[TBL] [Abstract] [Full Text] [Related]
18. Anoikis regulator GLI2 promotes NC cell immunity escape by TGF-β-mediated non-classic hedgehog signaling in colorectal cancer: based on artificial intelligence and big data analysis.
Shanshan Z; Fanfei D; Xuan S; Huina L; Ye Z; Jiayu L; Shuo Z; Xue P; Yingye P; Chengjun J; Hang P; Li L
Aging (Albany NY); 2023 Dec; 15(24):14733-14748. PubMed ID: 38159250
[TBL] [Abstract] [Full Text] [Related]
19. Identification of the six-hormone secretion-related gene signature as a prognostic biomarker for colon adenocarcinoma.
Jia X; Zhang T; Lv X; Du H; Sun Y; Guan Y
Cancer Biomark; 2023; 38(4):523-535. PubMed ID: 38143338
[TBL] [Abstract] [Full Text] [Related]
20. ZEB1 hypermethylation is associated with better prognosis in patients with colon cancer.
Fernandez-De-Los-Reyes I; Gomez-Dorronsoro M; Monreal-Santesteban I; Fernandez-Fernandez A; Fraga M; Azcue P; Alonso L; Fernandez-Marlasca B; Suarez J; Cordoba-Iturriagagoitia A; Guerrero-Setas D
Clin Epigenetics; 2023 Dec; 15(1):193. PubMed ID: 38093305
[TBL] [Abstract] [Full Text] [Related]
[Next]
